Annual Report 2014 Annual Report 2014
Menu

BUSINESS DEVELOPMENT
2010–2014

This overview may include historically adjusted values in order to ensure comparability with 2014.

Merck Group → Key Figures

Show table
€ million 2010 2011 2012 2013 2014 Change in %
             
Earnings performance            
Total revenues 9,291 10,276 11,173 11,095 11,501 3.7
Sales 8,929 9,906 10,741 10,700 11,291 5.5
Operating result (EBIT) 1,113 1,132 964 1,611 1,762 9.4
Margin (% of sales) 12.5 11.4 9.0 15.1 15.6  
EBITDA 2,457 2,731 2,360 3,069 3,123 1.7
Margin (% of sales) 27.5 27.6 22.0 28.7 27.7  
One-time items –88 7 -605 –184 -265 43.9
EBITDA pre one-time items 2,545 2,724 2,965 3,253 3,388 4.1
Margin (% of sales) 28.5 27.5 27.6 30.4 30.0  
Profit before income tax 861 839 709 1,389 1,557 12.1
Profit after tax 642 618 579 1,209 1,165 -3.7
Earnings per share (in €)1 1.45 1.39 1.30 2.77 2.66 -4.0
             
Assets and liabilities            
Total assets 22,388 22,122 21,643 20,819 26,010 24.9
Non-current assets 16,724 15,723 15,017 13,434 15,530 15.6
– thereof intangible assets (incl, goodwill) 12,484 11,764 10,945 9,867 11,396 15.5
– thereof property, plant and equipment 3,241 3,113 2,954 2,647 2,990 13.0
Current assets 5,664 6,399 6,626 7,385 10,480 41.9
– thereof cash and cash equivalents 944 938 730 981 2,879 193.5
– thereof trade accounts receivable 2,296 2,328 2,115 2,021 2,236 10.6
– thereof inventories 1,674 1,691 1,534 1,474 1,660 12.6
Financial liabilities 5,484 5,539 4,454 3,698 5,637 52.4
– thereof current 356 1,394 1,091 440 2,076 -
– thereof non-current 5,127 4,145 3,362 3,257 3,561 9.3
Net equity 10,372 10,494 10,415 11,069 11,801 6.6
             
Liquidity            
Capital expenditure on intangible assets2 104 80 144 110 143 30.8
Capital expenditure on property, plant and equipment2 396 366 329 407 481 18.1
Business free cash flow 1,275 2,262 2,969 2,960 2,605 –12.0
Net financial debt 4,484 3,484 1,926 307 559 82.3
             
Other key data            
Equity ratio (in %) 46.3 47.4 48.1 53.2 45.4  
Research and development3 1,397 1,514 1,511 1,507 1,704 13.1
Dividend per share (in €) 1.25 1.50 1.70 1.90 1.00 4 -
Employees (number as of December 31) 40,562 40,676 38,847 38,154 39,639 3.9
1 Taking into account the share split; previous year’s figures have been adjusted accordingly;
2 According to the Consolidated Cash Flow Statement.
3 Fiscal 2013 has been adjusted, see “Accounting and measurement principles” in the Notes to the Consolidated Financial Statements.
4 The proposal on the appropriation of profits for 2014 takes into account the share split.

28 KB

Nach oben